Factors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer

Abstract

PurposeThe delayed diagnosis of colorectal cancer (CRC) may be attributable to sociodemographic characteristics, to aspects of tumour histopathology or to the functioning of the health system. We seek to determine which of these factors most influences prolonged patient-attributable delay (PPAD) in the diagnosis and treatment of CRC.Materials and MethodsA prospective, multicentre observational study was conducted in 22 Spanish hospitals. In total, 1,785 patients were recruited to the study between 2010 and 2012 and underwent elective or urgent surgery. PPAD is considered to occur when the time elapsed between a patient presenting the symptom and him/her seeking attention from the primary care physician or hospital emergency department exceeds 180 days. A bivariate analysis was performed to assess differences in variables segmented by tumour location and patient delay. Multivariate logistic regression analysis was performed on the outcome variable, PPAD.ResultsThe rate of PPAD among this population was 12.1%. PPAD was significantly associated with altered bowel rhythm (odds ratio [OR], 1.36; 95% confidence interval [CI], 1.02 to 1.83) and with adenocarcinoma histology, in comparison with mucinous adenocarcinoma (OR, 2.03; 95% CI, 1.11 to 3.71). Other sociocultural factors and clinicopathological features were not independent predictors of PPAD.ConclusionMany patients do not consider altered bowel rhythm an alarming symptom, warranting a visit to the doctor. PPAD could be reduced by improving health education, raising awareness of CRC-related symptoms.

Advanced stage presentation and its determinant factors among colorectal cancer patients in Amhara regional state Referral Hospitals, Northwest Ethiopia

“…Patients who delayed visiting a health care facility after the appearance of the first sign/ symptom presented with advanced stage than those who did not. This is supported by studies in Puerto Rico [34], Botswana [35], and Spain [36]. This could be since if patients don't visit health care facilities and their physicians as early as possible after the sign/symptom, the disease could metastasize and disseminate to different organs [37].…”

Targeting Receptor Kinases in Colorectal Cancer

“…Most cases of colon cancer begin as small, benign adenomatous polyps that over time can become malignant. Since during these early stages CRC symptoms may be minimal or non-existent, the prompt reaction of patients to the first symptoms [3,4] and early diagnosis will contribute to treatment success and increase patients’ survival in over 90% of cases [5].…”

Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy

“…Colorectal cancer (CRC) is the third most common cancer in men and the second most common cancer in women worldwide 1 . More than 1.8 million new CRC cases and 881,000 deaths related to CRC were reported in 2018, accounting for approximately 1 in 10 cancer cases and deaths 2 .…”